Cargando…
Use of laboratory-developed assays in global HIV-1 treatment-monitoring and research
There has been a surge in the emergence of HIV-1 drug resistance in Low and Middle-Income Countries (LMICs) due to poor drug-adherence and limited access to viral load testing, the current standard for treatment-monitoring. It is estimated that only 75% of people living with HIV (PLWH) worldwide hav...
Autores principales: | Malisa, Jemima, Manak, Mark, Michelo, Clive, Imami, Nesrina, Kibirige, Catherine N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026793/ https://www.ncbi.nlm.nih.gov/pubmed/36941272 http://dx.doi.org/10.1038/s41598-023-31103-y |
Ejemplares similares
-
Discrepant Amplification Results during the Development of an Assay Leads to Reclassification of Two AIDS Reagent Repository HIV-2 Isolates as HIV-1
por: Jagodzinski, Linda L., et al.
Publicado: (2014) -
Multifarious immunotherapeutic approaches to cure HIV-1 infection
por: Imami, Nesrina, et al.
Publicado: (2015) -
Development of a sensitive, quantitative assay with broad subtype specificity for detection of total HIV-1 nucleic acids in plasma and PBMC
por: Kibirige, C. N., et al.
Publicado: (2022) -
The Use of Ultra-Sensitive Molecular Assays in HIV Cure-Related Research
por: Kibirige, Catherine
Publicado: (2013) -
Author Correction: Development of a sensitive, quantitative assay with broad subtype specificity for detection of total HIV-1 nucleic acids in plasma and PBMC
por: Kibirige, C. N., et al.
Publicado: (2022)